EUROSPINE 2026 — Spine in Motion Gothenburg, 7–9 October 2026

Degenerative Thoracolumbar

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion for Single-Level Degenerative Disease: A Five-Year Matched Cohort Analysis

S. Shaikh1, G. Abdelmalek1, D. Coban1, C. Emami1, N. Sahai1, K. Hwang1, K. Sinha1

  1. St. Joseph's University Medical Center, Paterson, United States of America
Poster 000984: Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion for Single-Level Degenerative Disease: A Five-Year Matched Cohort Analysis
Abstract no.
000984
Topic
Degenerative Thoracolumbar
Author
S. Shaikh
Open full e-poster

Opens at full size in a new tab — zoom in to read the detail.

Abstract PDF

Abstract

Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) has been adopted to reduce perioperative morbidity compared with open TLIF. While short-term benefits are well established, long-term data comparing revision patterns, fusion durability, and patient-reported outcomes remain limited, particularly beyond five years. This study compared five-year clinical and radiographic outcomes following MIS-TLIF versus open TLIF for single-level degenerative lumbar pathology.

A retrospective matched cohort study was performed at a single institution including adult patients (≥18 years) undergoing single-level TLIF between January 2012 and December 2015. Exclusion criteria included multilevel fusion, non-degenerative indications, incomplete data, or <5 years follow-up. Patients were matched 1:1 (MIS-TLIF vs open TLIF) on age, sex, BMI, operative level, and diagnosis (45 per cohort; N=90). MIS-TLIF utilized a tubular retractor system with percutaneous screws; open TLIF used a midline approach with open screw placement. Outcomes included operative time, estimated blood loss (EBL), revision surgery and timing, subsidence (>3 mm), five-year fusion status, and PROMs (ODI, VAS). Statistical significance was set at p<0.05.

Baseline characteristics were well balanced between cohorts. Mean follow-up was longer in the MIS-TLIF group (97.9 vs 90.3 months, p=0.004). Operative time was similar between groups (186.2 vs 178.1 minutes, p=0.072), while EBL was significantly lower with MIS-TLIF (83.2 vs 235.6 mL, p<0.001). Overall revision rates were comparable (15.6% MIS vs 13.3% open, p=0.764). Revision indications included pseudarthrosis, adjacent segment disease (ASD), residual stenosis, epidural hematoma, and infection, with no significant between-group differences for individual indications. ASD-related revisions were numerically higher after open TLIF, whereas pseudarthrosis-related revisions were numerically higher after MIS-TLIF. Mean time to revision was shorter following MIS-TLIF (23.9 vs 42.1 months, p=0.015). Subsidence rates remained low and comparable at all time points, including five years (8.9% MIS vs 11.1% open, p=0.725). Five-year fusion rates were similarly high (89.1% MIS vs 91.1% open). Both cohorts demonstrated significant improvement in ODI and VAS scores; at five years, ODI was comparable, while VAS back and leg pain modestly favored MIS-TLIF.

In a matched cohort with minimum five-year follow-up, MIS-TLIF was associated with lower blood loss and comparable long-term revision, fusion, and subsidence outcomes relative to open TLIF, with similar disability improvement and modestly lower pain scores at five years. Numerical differences in ASD- and pseudarthrosis-related revisions suggest potential directional tradeoffs that did not reach statistical significance, underscoring the need for larger cohorts to clarify approach-related differences in infrequent late endpoints.